摘要
钆塞酸二钠(Gd-EOB-DTPA)是肝胆特异性MRI对比剂,越来越广泛地在临床使用。国内相关技术专家结合国内外专家共识和参考文献,在临床实践中获得了大量扫描经验的积累,对Gd-EOB-DTPA增强MRI检查的扫描方案进行优化、增补和细化,对扫描适用人群、对比剂注射方案、扫描方案及图像质量控制等内容达成共识。旨在规范Gd-EOB-DTPA增强MRI检查的检查方案,更好地服务于影像诊断和制订临床治疗策略。
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid(Gd-EOB-DTPA)is a hepatobiliary-specific magnetic resonance imaging(MRI)contrast agent and has been widely used in clinical practice.With reference to the expert consensus and references in China and foreign countries,the experts in China obtained plenty of scan experience in clinical practice,optimized,supplemented,and refined the scan regimen of Gd-EOB-DTPA-enhanced MRI,and thus reached a consensus on intended population,contrast agent injection,scan regimen,and quality control,in order to standardize the regimen of Gd-EOB-DTPA-enhanced MRI and help with imaging diagnosis and the development of clinical treatment strategies.
出处
《临床肝胆病杂志》
CAS
北大核心
2020年第3期519-521,共3页
Journal of Clinical Hepatology
关键词
造影剂
钆塞酸二钠
磁共振成像
共识
contrastmedia
gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid
magneti cresonance imaging
consensus